Stay updated on Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about using “Super Intelligence” instead of “Artificial Intelligence” appears above the existing 403 error page. The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:06:23.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:13:03.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page for NCT03576963 now renders a 403 Forbidden response. It replaces the study content with a 403 message and a minimal header, blocking access to the study details.
    Difference
    19%
    Check dated 2026-09-23T01:09:00.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 has been added, replacing the previous v3.6.6. This signals a backend/page revision rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-09-16T00:09:13.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.5 to v3.6.6 in the footer, indicating a new version of the site’s software; this change does not modify core content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-09-01T19:18:29.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.4 to v3.6.5, signaling a minor page update. No study content or user-facing details appear to be changed.
    Difference
    0.1%
    Check dated 2026-08-11T06:19:36.000Z thumbnail image

Stay in the know with updates to Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.